Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Westover

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Cancer Research|July 24, 2021
Lentiviral-Driven Discovery of Cancer Drug Resistance MutationsPaul Yenerall, Rahul K Kollipara, Kimberley Avila, et al.
Advances in Radiation Oncology|September 23, 2022
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung CancerEric J Hsu, Jameson T Mendel, Kristin A Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12CJohn C Hunter, Deepak Gurbani, Scott B Ficarro, et al.
Journal of Clinical Medicine|February 13, 2026
Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) for Patients with Lung Tumors and Severe Pulmonary DiseaseKenneth D Westover, Ruiqi Li, Stetler Tanner, et al.
Cell Death & Disease|May 11, 2018
GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 levelQing Li, Xi Wei, Zhi-Wei Zhou, et al.
JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.
The Journal of Biological Chemistry|October 7, 2024
Experimental variables determine the outcome of RAS-RAS interactionsZhiwei Zhou, Tra Ly Nguyen, Xingxiao Li, et al.
European Journal of Medicinal Chemistry|May 21, 2022
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffoldZhengnian Li, Ryosuke Ishida, Yan Liu, et al.
Cell Chemical Biology|August 7, 2020
Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA ProcessingYan Liu, Fleur M Ferguson, Lianbo Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
PD-L1<sup>P146R</sup> is prognostic and a negative predictor of response to immunotherapy in gastric cancerQing Li, Zhi-Wei Zhou, Jia Lu, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancer Research|July 24, 2021
Lentiviral-Driven Discovery of Cancer Drug Resistance MutationsPaul Yenerall, Rahul K Kollipara, Kimberley Avila, et al.
Advances in Radiation Oncology|September 23, 2022
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung CancerEric J Hsu, Jameson T Mendel, Kristin A Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12CJohn C Hunter, Deepak Gurbani, Scott B Ficarro, et al.
Journal of Clinical Medicine|February 13, 2026
Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) for Patients with Lung Tumors and Severe Pulmonary DiseaseKenneth D Westover, Ruiqi Li, Stetler Tanner, et al.
Cell Death & Disease|May 11, 2018
GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 levelQing Li, Xi Wei, Zhi-Wei Zhou, et al.
JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.
The Journal of Biological Chemistry|October 7, 2024
Experimental variables determine the outcome of RAS-RAS interactionsZhiwei Zhou, Tra Ly Nguyen, Xingxiao Li, et al.
European Journal of Medicinal Chemistry|May 21, 2022
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffoldZhengnian Li, Ryosuke Ishida, Yan Liu, et al.
Cell Chemical Biology|August 7, 2020
Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA ProcessingYan Liu, Fleur M Ferguson, Lianbo Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
PD-L1<sup>P146R</sup> is prognostic and a negative predictor of response to immunotherapy in gastric cancerQing Li, Zhi-Wei Zhou, Jia Lu, et al.
Pageof 10